Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 55

Results For "operations"

932 News Found

Aster DM Healthcare appoints Dr. Nitish Shetty as India CEO
People | March 18, 2023

Aster DM Healthcare appoints Dr. Nitish Shetty as India CEO

He is Proficient in overseeing and leading teams for running successful business operations


Briefs: Man Industries, Jeevan Scientific Technology, Unichem and Torrent Pharmaceuticals
Drug Approval | March 18, 2023

Briefs: Man Industries, Jeevan Scientific Technology, Unichem and Torrent Pharmaceuticals

Man Industries (India) Limited has received a new export order of approximately Rs. 1,300 crores.


LifeSigns raises Pre-Series A
News | March 15, 2023

LifeSigns raises Pre-Series A

A funding to expand operations and provide better patient care


Cepheid launches its first manufacturing unit in India
News | March 15, 2023

Cepheid launches its first manufacturing unit in India

The facility has been set up to manufacture tuberculosis testing cartridges


Precision appoints John Hubbard, PhD, as Board of Directors Chair
People | March 14, 2023

Precision appoints John Hubbard, PhD, as Board of Directors Chair

Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.


Aptar appoints Julie Xing to its Board of Directors
People | March 07, 2023

Aptar appoints Julie Xing to its Board of Directors

Julie is recognized as a highly engaging multi-cultural leader skilled in fluidly partnering with cross-functional teams to deliver results.


Neogen Chemicals to acquire 100% stake in BuLi Chemicals India from Livent
News | March 06, 2023

Neogen Chemicals to acquire 100% stake in BuLi Chemicals India from Livent

This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry


Celanese collaborates with Alessa Therapeutics for the advancement of oncology treatments
News | March 04, 2023

Celanese collaborates with Alessa Therapeutics for the advancement of oncology treatments

The collaboration will focus on developing a localized and sustained-release drug delivery system for oncology patients


Venus Remedies awarded Saudi GMP approval for all its production facilities in Baddi
Drug Approval | February 28, 2023

Venus Remedies awarded Saudi GMP approval for all its production facilities in Baddi

The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region


MEI Pharma and Infinity Pharmaceuticals inks merger agreement to advance three promising clinical oncology candidates
Clinical Trials | February 24, 2023

MEI Pharma and Infinity Pharmaceuticals inks merger agreement to advance three promising clinical oncology candidates

Projected ~US$100 million cash balance of combined company expected to fund operations through mid-2025 and to clinical data over the next 12 to 24 months